Antigenics Reports Positive Trial Results for Cancer Vaccine

Drug Industry Daily
KEYWORDS Drug Discount / Trial
A A

Biotechnology firm Antigenics is preparing to launch a pivotal trial for its cancer vaccine Oncophage — a move that comes in the wake of preliminary data from a late-stage clinical trial that showed the drug extended the survival of advanced skin cancer patients.

To View This Article:

Login

Subscribe To Drug Industry Daily